Epitalon: The Pineal Peptide Resetting Your Aging Clock
May 5, 2026
The most studied anti-aging peptide on Earth has thirty years of human data, lengthens telomeres in cell culture, restores melatonin rhythm, and reduces all-cause mortality
SARMs
SARMs Articles
SARMs (Selective Androgen Receptor Modulators) are lab-made chemicals that act a bit like “targeted” steroids for your body. They’re designed to mainly affect muscles (and sometimes bones), helping with growth and strength in those areas.
Read More
Semax: The Cognitive Enhancer Born From Soviet Stroke Research
May 5, 2026
The Russians had a stroke recovery drug in clinical use for fifteen years before American neurologists noticed it had nootropic effects strong enough to outclass
Swiss Chems Review: Tony Huge Community Weighs In on SARMs
May 4, 2026
The research chemical industry continues to face scrutiny as publications like OCNJ Daily examine the legitimacy of suppliers offering sarms and peptides. A recent Swiss
NAD+ Skincare Revolution: Tony Huge Community Reviews
May 4, 2026
The intersection of advanced biohacking and skincare technology has reached a new milestone with the emergence of NAD+ complex serums, capturing attention across the longevity
Anti-Aging Supplement Breakthrough: What Tony Huge’s Research Shows
May 4, 2026
A groundbreaking human clinical trial has demonstrated that a common supplement can actually reverse markers of premature aging, marking a significant milestone in the anti-aging
GI Innovation Anti-Aging Trial: Breakthrough for Longevity
May 4, 2026
The anti-aging and longevity research landscape has taken a significant leap forward with GI Innovation’s recent clearance for a Phase 2a anti-aging trial in Australia.
LGD-4033 vs RAD-140: Best SARM for Dry Mass Gains
May 4, 2026
LGD-4033 vs RAD-140: the ultimate Comparison for Dry Mass Gains When it comes to building dry, lean muscle mass without the bloat and water retention
Anti-Aging Breakthroughs: What Tony Huge’s Community Needs to Know
May 3, 2026
The anti-aging research landscape is accelerating at an unprecedented pace, with Forbes recently highlighting that ‘extraordinary’ breakthroughs in longevity science ‘will happen faster than people
Gene Therapy Anti-Aging: Tony Huge’s Biohacking Revolution
May 3, 2026
The longevity revolution is accelerating at breakneck speed, and the latest developments in gene therapy anti-aging research are capturing the attention of biohackers and longevity
Sugar-Coated Nanotherapy Breakthrough: Revolutionary Alzheimer’s Treatment Shows Dramatic Neuron Survival
May 2, 2026
The biohacking world just witnessed a paradigm shift that could revolutionize how we approach neurodegenerative diseases. A breakthrough nanotherapy Alzheimer’s treatment using sugar-coated nanoparticles has
GLP-1 Pharmacogenomics: The 23andMe Variants That Predict Tirzepatide Side Effects
May 2, 2026
TL;DR April 2026 Nature paper from 23andMe Research Institute identifies two missense variants — GLP1R rs10305420 (p.Pro7Leu) and GIPR rs1800437 (p.Glu354Gln) — that predict tirzepatide
Tesamorelin (Egrifta): The 44-Amino-Acid GHRH That Strips Visceral Fat And Sharpens The Brain
May 2, 2026
TL;DR What it is: Tesamorelin (brand name Egrifta) — a 44-amino-acid GHRH analog that stimulates the body’s own growth hormone release in natural pulses, not
GLP-1 Muscle Loss Concerns: What Tony Huge’s Community Needs to Know
May 1, 2026
The bodybuilding and biohacking communities have been closely monitoring the rise of glp-1 receptor agonists like Ozempic and Wegovy, particularly concerning their potential impact on
Myostatin Blockers + GLP-1: Game-Changer for Muscle Preservation
May 1, 2026
A groundbreaking development in the intersection of weight loss and muscle preservation has emerged from recent clinical research, revealing how myostatin inhibition could revolutionize the
SARM Liver Toxicity: What Bodybuilders Must Know
May 1, 2026
A groundbreaking study published in Cureus has sent shockwaves through the bodybuilding and performance enhancement community, revealing previously underestimated liver toxicity risks associated with Selective